Results 141 to 150 of about 9,855 (176)
Some of the next articles are maybe not open access.

Candida auris and Nosocomial Infection

Current Drug Targets, 2020
The existence of the multi-drug resistant (MDR) pathogenic fungus, Candida auris came to light in 2009. This particular organism is capable of causing nosocomial infections in immunecompromised persons. This pathogen is associated with consistent candidemia with high mortality rate and presents a serious global health threat.
Sweety, Dahiya   +7 more
openaire   +2 more sources

The Epidemiology and Prevention of Candida auris

Current Infectious Disease Reports, 2019
Candida auris has recently emerged as a pathogen with the potential for nosocomial transmission and outbreaks. The aim of this review is to summarize the global dissemination of this pathogen, characterize patient and facility characteristics associated with infection and outbreaks, and outline evidence to support interventions to prevent of ...
Graham M, Snyder, Sharon B, Wright
openaire   +2 more sources

Emergence of Candida auris in Russia

Journal of Hospital Infection, 2019
This paper reports the emergence of Candida auris infections in an intensive care unit at a hospital in Moscow. Forty-nine cases were diagnosed in 2016-2017, and the risk factors and antifungal susceptibilities are described. The 30-day all-cause mortality for 19 bloodstream infections in patients who did not receive appropriate antifungal therapy was ...
N E, Barantsevich   +9 more
openaire   +2 more sources

Isolation of Candida auris in Clinical Specimens

2022
Candida auris is a multidrug-resistant yeast causing healthcare-associated outbreaks of blood stream infections worldwide. Currently, C. auris isolation and identification is complicated by issues such as misidentification and long turnaround time associated with application of commonly used diagnostic tools.
Anamika Yadav   +2 more
openaire   +2 more sources

Candida auris: Epidemiology and Antifungal Strategy

open access: yesAnnual Review of Medicine
Candida auris is a recently emerged fungal pathogen that causes severe infections in healthcare settings around the globe. A feature that distinguishes C. auris from other fungal pathogens is its high capacity to colonize skin, leading to widespread outbreaks in healthcare
Jeniel E Nett, Emily F Eix
exaly   +3 more sources

Susceptibility Testing of Candida auris Isolates

2022
Susceptibility testing of isolates of Candida auris is helpful as a guide to the selection of the most appropriate antifungal agent for treatment as different clades and strains within clades often demonstrate markedly different susceptibility profiles.
Elizabeth M, Johnson, Andrew M, Borman
openaire   +2 more sources

CANDIDA AURIS ENFEKSİYONLARI

2022
Candida auris is an emerging but important pathogen due to its ability to cause epidemics and antifungal resistance. This factor, which was first detected in 2009, has rapidly started to be seen globally, and there have been cases detected in our country in recent years. However, much remains unknown about this current global public health pathogen. In
KARAAYVAZ, Serhat, ALKAN, Sevil
openaire   +1 more source

Management of Candida auris

JAMA
This JAMA Insights Clinical Update discusses the diagnosis, treatment, prognosis, and infection-prevention measures for Candida auris.
Anastasia, Wasylyshyn, Emily K, Stoneman
openaire   +2 more sources

Innate immune response to Candida auris

Current Opinion in Microbiology
Candida auris, a newly emergent fungal species, has been spreading in health care systems and causing life-threatening infections. Intact innate immunity is essential for protection against many invasive fungal infections, including candidiasis. Here, we highlight recent studies exploring immune interactions with C.
Ashley M, Holt, Jeniel E, Nett
openaire   +2 more sources

Wastewater surveillance of Candida auris in Baltimore

International Journal of Hygiene and Environmental Health
Candida auris (C. auris), an opportunistic fungus causing disease, poses a growing global health concern due to its significant mortality rate, resistance to antifungal treatment, and ability to persist in healthcare settings. Over a span of 47 weeks, untreated wastewater samples were regularly gathered from two wastewater treatment plants (referred to
Daniel A. Nwaubani   +4 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy